Transfected parvalbumin alters calcium homeostasis in teratocarcinoma PCC7 cells

European Journal of Cell Biology

Volumn 69, Issue 4, 1996, Pages 360-367

  Müller, Bernhard K ^a   Kabos, Peter ^b   Belhage, Bo ^c   Neumann, Toomas ^b   Kater, Stanley B ^b  

^a MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY   (Germany)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Calcium homeostasis; EF hand calcium binding proteins; Neuroprotection; Parvalbumin; Teratocarcinoma

Indexed keywords

CALCIMYCIN; CALCIUM; CALCIUM BINDING PROTEIN; COMPLEMENTARY DNA; FURA 2; PARVALBUMIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSFECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TERATOCARCINOMA;

EID: 0029947294     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Andressen, C., I. Blümcke, M. R. Celio: Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res. 271, 181-208 (1993).
2. Baimbridge, K. G., M. R. Celio, J. H. Rogers: Calcium-binding proteins in the nervous system. Trends Neurosci. 15, 303-308 (1992).
3. Berchtold, M. W.: Cloning of the rat parvalbumin gene. Methods Enzymol. 139, 317-325 (1987).
4. Berchtold, M. W.: Parvalbumin genes from human and rat are identical in intron/exon organization and contain highly homologous regulatory elements and coding sequences. J. Mol. Biol. 210, 417-427 (1989).
5. Blaustein, M. P.: Calcium transport and buffering in neurons. Trends Neurosci. 11, 438-443 (1988).
6. Celio, M. R., C. W. Heizmann: Calcium-binding protein parvalbumin is associated with fast contracting muscle fibers. Nature 297, 504-509 (1982).
7. Celio, M. R.: Parvalbumin in most GABA-containing neurons of the rat cerebral cortex. Science 231, 995-997 (1986).
8. Celio, M. R.: Calbindin D28K and parvalbumin in the rat nervous system. Neuroscience 35, 375-475 (1990).
9. Chard, P. S., D. Bleakman, S. Christakos, C. S. Fullmer, R. J. Miller: Calcium buffering properties of calbindin-D28K and parvalbumin in rat sensory neurons. J. Physiol. 472, 341-357 (1993).
10. Choi, D. W.: Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465-467 (1988).
11. Collazo, D., H. Takahashi, R. D. G. McKay: Cellular targets and trophic functions of neurotrophin - 3 in the developing rat hippocampus. Neuron 9, 643-656 (1992).
12. Crumpton, M. J., J. R. Dedman: Protein terminology tangle. Nature 345, 212 (1990).
13. Easty, D. M., G. C. Easty, A. Baici, R. L. Carter, S. A. Cederholm-Williams, H. Felix, B. Gusterson, G. Haemmerli, I. Hauser-Urfer, C. W. Heizmann, M. Mareel, B. Stehrenberger, P. Strauli: Biological parameters of ten human squamos carcinoma cell lines: an overview. Eur. J. Cancer, Clin. Oncol. 22, 617-634 (1986).
14. Epstein, P., A. R. Means, M. W. Berchtold: Isolation and characterization of a rat parvalbumin gene and a full length cDNA. J. Biol. Chem. 261, 5886-5891 (1986).
15. Grynkiewicz, D., G. Neufeld, L. Schweigerer: A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450 (1985).
16. Heizmann, C. W., M. R. Celio: Immunolocalization of parvalbumin. Methods Enzymol. 139, 552-570 (1987).
17. Heizmann, C. W.: Novel calcium-binding proteins in tumor cells. Methods Enzymol. 139, 297-314 (1987).
18. Heizmann, C. W., W. Hunziker: Intracellular calcium-binding proteins: more sites than insights. Trends Biochem. Sci 16, 98-103 (1991).
19. Heizmann, C. W., K. Braun: Changes in Ca2+-binding proteins in human neurodegenerative disorders. Trends Neurosci. 15, 259-264 (1992).
20. Heizmann, C. W., M. W. Berchtold: Expression of parvalbumin and other calcium-binding proteins in normal and tumor cells: a topical review. Cell Calcium 8, 1-41 (1987).
21. Iacopino, A. M., S. Christakos: Specific reduction of calcium-binding protein (28 kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 87, 4078-4082 (1990).
22. Iacopino, A. M., W. B. Rhoten, S. Christakos: Calcium binding protein (calbindin-D28K) gene expression in the developing and aging mouse cerebellum. Mol. Brain Res. 8, 283-290 (1990).
23. Iacopino, A. M., S. Christakos, D. German, P. K. Sonsalla, C. A. Altar: Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Mol. Brain Res. 13, 251-261 (1992).
24. Kosaka, T., L. Kosaka, T. Nakayama, W. Hunziker, C. W. Heizmann: Axons and axon terminals of cerebellar Purkinje cells and basket cells have higher levels of parvalbumin immunoreactivity than somata and dendrites: quantitative analysis by immunogold labeling. Exp. Brain Res. 93, 483-491 (1993).
25. Kretsinger, R. H.: Structure and evolution of calcium-modulated proteins. CRC Crit. Rev. Biochem. 8, 119-174 (1980).
26. Lledo, P.-M., B. Somasundaram, A. J. Morton, P. C. Emson, W. T. Mason: Stable transfection of calbindin-D28K into the GH3 cell line alters calcium currents and intracellular calcium homeostasis. Neuron 9, 943-954 (1992).
27. Lowenstein, D. H., M. F. Miles, F. Hatam, T. McCabe: Up-regulation of calbindin-D28K mRNA in the rat hippocampus following focal stimulation of the perforant path Neuron 6, 627-633 (1991).
28. MacManus, J. P., D. C. Watson, M. Yaguchi: The complete amino acid sequence of oncomodulin - a parvalbumin-like calcium-binding protein from Morris hepatoma tc. Eur. J. Biochem. 136, 9-17 (1983).
29. Mattson, M. P., B. Rychlik, C. Chu, S. Christakos: Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D28K in cultured hippocampal neurons. Neuron 6, 41-51 (1991).
30. Moews, P. G., R. H. Kretsinger: Refinement of the structure of carp muscle calcium-binding parvalbumin by model building and difference Fourier analysis. J. Mol. Biol. 91, 201-228 (1975).
31. Moncrief, N. D., R. H. Kretsinger, M. Goodman: Evolution of EF-hand calcium-modulated proteins. 1. Relationships based on amino acid sequences. J. Mol. Evol. 30, 522-562 (1990).
32. Morgan, D. W., A. F. Welton, A. E. Heick, S. Christakos: Specific in vitro activation of Ca, Mg-ATPase by vitamin D-dependent rat renal calcium-binding protein (calbindin-D28K). Biochem. Biophys. Res. Commun. 138, 547-553 (1986).
33. Muir, E. M., D. E. M. Lawson, F. V. Sepulveda, J. A. O'Brien, M. Harding: Calbindin-D28K expression in transfected mouse NIH3T3 cells. Cell Calcium 14, 349-358 (1993).
34. Nitsch, C., A. L. Scotti, A. Sommacal, G. Kalt: GABAergic hippocampal neurons resistant to ischemia induced delayed neuronal death contain the calcium-binding protein parvalbumin. Neurosci. Lett. 105, 263-268 (1989).
35. Oberholtzer, J. C., C. Buettger, M. C. Summers, M. F. Matschinsky: The 28-kDa calbindin-D is a major calcium-binding protein in the basilar papilla of the chick. Proc. Natl. Acad. Sci. USA 85, 3387-3390 (1988).
36. Okayama, H., C. Chen: Calcium phophate mediated gene transfer into established cell lines. In: E. J. Murray (ed.): Gene Transfer and Expression Protocols. pp. 15-22. Humana Press. Totowa, NJ 1991.
37. Persechini, A., N. Moncrief, R. H. Kretsinger: The EF-hand family of calcium-modulated proteins. Trends Neurosci. 12, 462-467 (1989)
38. Pfeiffer, S. E., H. Jacob, K. Mikoshiba, P. Dubois, J. L. Guenet, J.-F. Nicolas, J. Gaillard, G. Chevance, F. Jacob: Differentiation of a teratocarcinoma line: preferential development of cholinergic neurons. J. Cell Biol. 88, 57-66 (1981).
39. Pfyffer, G. E., G. Haemmerli, C. W. Heizmann: Calcium-binding proteins in human carcinoma cell lines. Proc. Natl. Acad. Sci. USA 81, 6632-6636 (1984).
40. Rassmussen, C. D., A. R. Means: The presence of parvalbumin in a nonmuscle cell line attenuates progression through mitosis. Mol. Endocrinol. 3, 588-596 (1989).
41. Scharfman, H. E., P. A. Schwartzkroin: Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science 246, 257-260 (1989).
42. Siesjö, B. K., F. Bengtsson: Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9, 127-140 (1989).
43. Sloviter, R. S.: Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J. Comp. Neurol. 280, 183-196 (1989).
44. Sloviter, R. S., A. L. Sollas, N. M. Barbara, K. D. Laxer: Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J. Comp. Neurol. 308, 381-396 (1991).
45. Tortosa, A., I. Ferrer: Parvalbumin immunoreactivity in the hippocampus of the gerbil after transient forebrain ischemia: a qualitative and quantitative sequential study. Neuroscience 55, 33-43 (1993).
46. Tsien, R. Y.: Fluorescence measurement and photochemical manipulation of cytosolic free calcium. Trends Neurosci. 11, 419-424 (1988).
47. Tymianski, M., M. C. Wallace, I Spigelman, M. Uno, P. L. Carlen, C. H. Tator, M. P. Charlton: Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 11, 221-235 (1993).